We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong income characteristics for investors to consider today, August 15th:
Ameriprise Financial, Inc. (AMP - Free Report) : This provider of financial products and services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 3.17%, compared with the industry average of 2.94%. Its five-year average dividend yield is 2.46%.
Best Buy Co., Inc. (BBY - Free Report) : This specialty retailer of technology products, services, and solutions has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 2.99%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.61%.
Ares Capital Corporation (ARCC - Free Report) : This specialty finance company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.4% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 8.96%, compared with the industry average of 8.90%. Its five-year average dividend yield is 9.45%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Income Stocks to Buy for August 15th
Here are three stocks with buy rank and strong income characteristics for investors to consider today, August 15th:
Ameriprise Financial, Inc. (AMP - Free Report) : This provider of financial products and services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1% over the last 60 days.
Ameriprise Financial, Inc. Price and Consensus
Ameriprise Financial, Inc. price-consensus-chart | Ameriprise Financial, Inc. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 3.17%, compared with the industry average of 2.94%. Its five-year average dividend yield is 2.46%.
Ameriprise Financial, Inc. Dividend Yield (TTM)
Ameriprise Financial, Inc. dividend-yield-ttm | Ameriprise Financial, Inc. Quote
Best Buy Co., Inc. (BBY - Free Report) : This specialty retailer of technology products, services, and solutions has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Best Buy Co., Inc. Price and Consensus
Best Buy Co., Inc. price-consensus-chart | Best Buy Co., Inc. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 2.99%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.61%.
Best Buy Co., Inc. Dividend Yield (TTM)
Best Buy Co., Inc. dividend-yield-ttm | Best Buy Co., Inc. Quote
Ares Capital Corporation (ARCC - Free Report) : This specialty finance company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.4% over the last 60 days.
Ares Capital Corporation Price and Consensus
Ares Capital Corporation price-consensus-chart | Ares Capital Corporation Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 8.96%, compared with the industry average of 8.90%. Its five-year average dividend yield is 9.45%.
Ares Capital Corporation Dividend Yield (TTM)
Ares Capital Corporation dividend-yield-ttm | Ares Capital Corporation Quote
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>